Acknowledgement
Supported by : Ministry of Food and Drug Safety
References
- Nalefski EA, Kasibhatla S, Rao A. Functional analysis of the antigen binding site on the T cell receptor alpha chain. J Exp Med 1992; 175(6): 1553-1563. https://doi.org/10.1084/jem.175.6.1553
- Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302(5909): 575-581. https://doi.org/10.1038/302575a0
- Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem 2002; 71(1): 101-132. https://doi.org/10.1146/annurev.biochem.71.090501.150203
- McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M, Oettinger MA. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 1995; 83(3): 387-395. https://doi.org/10.1016/0092-8674(95)90116-7
- Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990; 248(4962): 1517-1523. https://doi.org/10.1126/science.2360047
- Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell 1989; 59(6): 1035-1048. https://doi.org/10.1016/0092-8674(89)90760-5
- Xu K, Liu H, Shi Z, Song G, Zhu X, Jiang Y, Zhou Z, Liu X. Disruption of the RAG2 zinc finger motif impairs protein stability and causes immunodeficiency. Eur J Immunol 2016; 46(4): 1011-1019. https://doi.org/10.1002/eji.201545896
- Villa A, Santagata S, Bozzi F, Imberti L, Notarangelo LD. Omenn syndrome: a disorder of Rag1 and Rag2 genes. J Clin Immunol 1999; 19(2): 87-97. https://doi.org/10.1023/A:1020550432126
- Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992; 68(5): 855-867. https://doi.org/10.1016/0092-8674(92)90029-C
- Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100(9): 3175-3182. https://doi.org/10.1182/blood-2001-12-0207
- Skarnes WC. Is mouse embryonic stem cell technology obsolete? Genome Biol 2015; 16(1): 109. https://doi.org/10.1186/s13059-015-0673-6
- Valera A, Perales JC, Hatzoglou M, Bosch F. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther 1994; 5(4): 449-456. https://doi.org/10.1089/hum.1994.5.4-449
- Scacheri PC, Crabtree JS, Novotny EA, Garrett-Beal L, Chen A, Edgemon KA, Marx SJ, Spiegel AM, Chandrasekharappa SC, Collins FS. Bidirectional transcriptional activity of PGKneomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 2001; 30(4): 259-263. https://doi.org/10.1002/gene.1072
- Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013; 153(4): 910-918. https://doi.org/10.1016/j.cell.2013.04.025
- Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science 2013: 339(6121): 819-823. https://doi.org/10.1126/science.1231143
- Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 2013; 31(3): 233-239. https://doi.org/10.1038/nbt.2508
- Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012; 337(6096): 816-821. https://doi.org/10.1126/science.1225829
- Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013; 154(6): 1380-1389. https://doi.org/10.1016/j.cell.2013.08.021
- Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014; 346(6213): 1258096. https://doi.org/10.1126/science.1258096
- Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014; 157(6): 1262-1278. https://doi.org/10.1016/j.cell.2014.05.010
- Lee JH, Park JH, Nam TW, Seo SM, Kim JY, Lee HK, Han JH, Park SY, Choi YK, Lee HW. Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout. Transgenic Res 2018: 241-251.
Cited by
- CRISPR/Cas9-mediated knockout of CD47 causes hemolytic anemia with splenomegaly in C57BL/6 mice vol.34, pp.4, 2018, https://doi.org/10.5625/lar.2018.34.4.302
- Implication of Porphyromonas gingivalis in colitis and homeostasis of intestinal epithelium vol.35, pp.1, 2018, https://doi.org/10.1186/s42826-019-0029-6
- RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches vol.51, pp.5, 2018, https://doi.org/10.1002/eji.202048880